Kisspeptin Dosage Guide & Research Calculator
This kisspeptin dosage guide summarizes reconstitution math, an embedded concentration calculator, and dose ranges for kisspeptin (commonly kisspeptin-10 and kisspeptin-54) reported in published preclinical and clinical-research literature. All figures below summarize parameters reported in published preclinical or in-vitro research. They are provided for reference only and are not instructions for human or veterinary administration.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.
Kisspeptin reconstitution math & kisspeptin dosage calculator
Reconstituting a lyophilized peptide gives a solution with a known concentration. The formula is simple:
Worked example: Adding 2 mL of bacteriostatic water to a 5 mg vial of kisspeptin yields 2,500 mcg/mL. 0.10 mL (10 units on a U-100 insulin syringe) of that solution contains 250 mcg of peptide.
Enter your values
The total mass of lyophilized powder listed on the vial label.
The volume of bacteriostatic water added to the vial.
The amount, in micrograms, to model in your concentration math (1 mg = 1,000 mcg).
Display volume in U-100 syringe units or plain mL.
Based on your inputs
This tool performs unit conversion and concentration math for research planning. It is not medical advice, not a dose recommendation, and not intended for human or veterinary use.
Kisspeptin doses reported in published preclinical research
The figures below summarize Kisspeptin doses that appear in published animal-model or in-vitro studies. They describe what researchers have used in laboratory settings — they are not human administration protocols and are not dose recommendations.
| Research context | Dose reported | Notes |
|---|---|---|
| Published clinical research, intravenous bolus (kisspeptin-10) | 0.3–3 µg/kg | Range reported in published reproductive-endocrinology research. |
| Published clinical research, subcutaneous (kisspeptin-54) | 0.1–6.4 nmol/kg | Range reported in published clinical-research literature. |
| Preclinical rodent studies | 1–10 nmol | Central or peripheral doses used in animal-model literature. |
All values are research-context references compiled from published preclinical and in-vitro literature. Kisspeptin is supplied for laboratory and research use only.
Continue your Kisspeptin research
Kisspeptin research dosage — frequently asked questions
How is kisspeptin reconstituted for research?+
Lyophilized kisspeptin is dissolved in bacteriostatic water in the laboratory. Concentration is calculated as (vial mg × 1000) ÷ diluent mL, giving mcg per mL.
What concentration does 5 mg kisspeptin in 2 mL give?+
5 mg in 2 mL of bacteriostatic water yields a 2,500 mcg/mL solution. 0.10 mL (10 units on a U-100 insulin syringe) contains 250 mcg.
What kisspeptin doses are reported in published research?+
Published clinical research with kisspeptin-10 references intravenous bolus doses of roughly 0.3–3 µg/kg; kisspeptin-54 clinical research references subcutaneous doses around 0.1–6.4 nmol/kg. Preclinical rodent studies typically use 1–10 nmol.
Is this kisspeptin dosage guide for human use?+
No. Kisspeptin is supplied for laboratory and research use only. The figures above describe parameters reported in published research and are not human administration instructions.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.
